These findings support the dual roles of p53/p63 in mediating TORC1 inhibition following DNA damage and suggest that multiple mechanisms in tumors that suppress p53/p63 responses also abrogate the ability of the cancer cell to control TORC1, and, hence, cap-dependent translation, under conditions of DNA damage. The gene discussed is TP63; the disease is cancer.